Gahide, G.; Vendrell, J.-F.; Massicotte-Tisluck, K.; Caux, S.; Deschamps, S.; Noël-Lamy, M.; Belzile, F.; Roy, L.-O.; Fortin, D.
Safety of Cerebral Intra-Arterial Chemotherapy for the Treatment of Malignant Brain Tumours. J. Clin. Med. 2025, 14, 524.
https://doi.org/10.3390/jcm14020524
AMA Style
Gahide G, Vendrell J-F, Massicotte-Tisluck K, Caux S, Deschamps S, Noël-Lamy M, Belzile F, Roy L-O, Fortin D.
Safety of Cerebral Intra-Arterial Chemotherapy for the Treatment of Malignant Brain Tumours. Journal of Clinical Medicine. 2025; 14(2):524.
https://doi.org/10.3390/jcm14020524
Chicago/Turabian Style
Gahide, Gérald, Jean-François Vendrell, Karine Massicotte-Tisluck, Samuel Caux, Samuel Deschamps, Maxime Noël-Lamy, François Belzile, Laurent-Olivier Roy, and David Fortin.
2025. "Safety of Cerebral Intra-Arterial Chemotherapy for the Treatment of Malignant Brain Tumours" Journal of Clinical Medicine 14, no. 2: 524.
https://doi.org/10.3390/jcm14020524
APA Style
Gahide, G., Vendrell, J.-F., Massicotte-Tisluck, K., Caux, S., Deschamps, S., Noël-Lamy, M., Belzile, F., Roy, L.-O., & Fortin, D.
(2025). Safety of Cerebral Intra-Arterial Chemotherapy for the Treatment of Malignant Brain Tumours. Journal of Clinical Medicine, 14(2), 524.
https://doi.org/10.3390/jcm14020524
